SCHEMBL19281135

SCHEMBL19281135

O=C1CC2(CCN(C(=O)OCc3ccccc3)CC2)Oc2ccc(F)cc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 1/20 0.64
KMT2A Q03164 2/20 0.62
HDAC3 O15379 7/20 0.52
HDAC4 P56524 7/20 0.52
HDAC1 Q13547 7/20 0.52
HDAC7 Q8WUI4 7/20 0.52
HDAC2 Q92769 7/20 0.52
HDAC10 Q969S8 7/20 0.52
HDAC11 Q96DB2 7/20 0.52
HDAC8 Q9BY41 7/20 0.52
HDAC6 Q9UBN7 7/20 0.52
HDAC9 Q9UKV0 7/20 0.52
HDAC5 Q9UQL6 7/20 0.52
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 4/20 0.50
HPGD P15428 4/20 0.50
HSD17B10 Q99714 3/20 0.50
CASP1 P29466 2/20 0.50
GLA P06280 1/20 0.50
CASP7 P55210 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31398580 0.94 HSD11B1 (0.60) HSD11B1KMT2AHDAC3HDAC4HDAC1
SCHEMBL19281133 0.92 KMT2A (0.54) HSD11B1KMT2AHDAC3HDAC4HDAC1
SCHEMBL31398590 0.90 HSD11B1 (0.55) HSD11B1KMT2AHDAC3HDAC4HDAC1
SCHEMBL467592 0.87 SIGMAR1 (0.64) KMT2AHDAC3HDAC4HDAC1HDAC7
SCHEMBL31398594 0.87 HSD11B1 (0.48) HSD11B1KMT2AKDM4EALDH1A1HSD17B10
SCHEMBL19281126 0.85 KMT2A (0.48) HSD11B1KMT2AKDM4EALDH1A1HPGD
SCHEMBL31398578 0.84 HSD11B1 (0.48) HSD11B1KMT2AHDAC3HDAC4HDAC1
SCHEMBL31398596 0.83 HSD11B1 (0.47) HSD11B1KMT2AHDAC3HDAC4HDAC1
SCHEMBL31398597 0.83 HSD11B1 (0.47) HSD11B1KMT2AHDAC3HDAC4HDAC1
SCHEMBL17708825 0.83 CHRNA7 (0.50) HSD11B1KMT2AHDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4731613-A1 SPIROCYCLIC PARP INHIBITORS AND METHODS OF USE Valo Health, Inc. (US) 2026-04-29 EP disclosed
WO-2024261710-A1 SPIROCYCLIC PARP INHIBITORS AND METHODS OF USE VALO HEALTH, INC. (US) 2024-12-26 WO disclosed
EP-2675812-B1 CHROMAN - SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2017-08-30 EP disclosed